(Total Views: 725)
Posted On: 12/11/2020 12:38:23 AM
Post# of 72444
My hope is if extra Brilacidin manufacturing funding, then it encompasses 2 of the following 3
Brilacidin ABSSSI antibiotic, part of DRIVE AB
The quote below is from page 20 of the IPIX Corporate Overview dated June 2020:
“Brilacidin is 1 of only 7 “qualifying” antibiotics* in development DRIVE AB** says would merit a proposed Market Entry Reward ($1bn) due to its ability to kill “critical” or “high priority” pathogens.”
Brilacidin OM
Brilacidin UC
We have probably 6 million already in the bank last month.
A previous PR during our 6 million holding stated we had enough B for covid Phase 2 and extra beyond the Phase 2. So what would this 5 million be directed to, anyone?
Heck, generous covid grants are going to antibodies for Phase 1 and covering antiviral drug in Phase 1 now and also for their Phase 2... why are we not seeing funds or applying if IND is imminent, esp having independent research from an RBL, directly part of NIAID.
Read More: https://investorshangout.com/post/view?id=597...z6gI4EX8QW
Brilacidin ABSSSI antibiotic, part of DRIVE AB
The quote below is from page 20 of the IPIX Corporate Overview dated June 2020:
“Brilacidin is 1 of only 7 “qualifying” antibiotics* in development DRIVE AB** says would merit a proposed Market Entry Reward ($1bn) due to its ability to kill “critical” or “high priority” pathogens.”
Brilacidin OM
Brilacidin UC
We have probably 6 million already in the bank last month.
A previous PR during our 6 million holding stated we had enough B for covid Phase 2 and extra beyond the Phase 2. So what would this 5 million be directed to, anyone?
Heck, generous covid grants are going to antibodies for Phase 1 and covering antiviral drug in Phase 1 now and also for their Phase 2... why are we not seeing funds or applying if IND is imminent, esp having independent research from an RBL, directly part of NIAID.
Read More: https://investorshangout.com/post/view?id=597...z6gI4EX8QW
(3)
(0)
